| EMT: Mechanisms and therapeutic implications M Singh, N Yelle, C Venugopal, SK Singh Pharmacology & therapeutics 182, 80-94, 2018 | 415 | 2018 |
| The ever-evolving role of mTOR in translation BD Fonseca, EM Smith, N Yelle, T Alain, M Bushell, A Pause Seminars in cell & developmental biology 36, 102-112, 2014 | 127 | 2014 |
| Introduction to cancer stem cells: past, present, and future D Bakhshinyan, AA Adile, MA Qazi, M Singh, MM Kameda-Smith, N Yelle, ... Cancer Stem Cells: Methods and Protocols, 1-16, 2018 | 26 | 2018 |
| A rapid in vitro methodology for simultaneous target discovery and antibody generation against functional cell subpopulations AML Nixon, A Duque, N Yelle, M McLaughlin, S Davoudi, NM Pedley, ... Scientific reports 9 (1), 842, 2019 | 11 | 2019 |
| Introduction to brain tumor stem cells N Yelle, D Bakhshinyan, C Venugopal, SK Singh Brain Tumor Stem Cells: Methods and Protocols, 1-9, 2019 | 8 | 2019 |
| Synchronous Optical and Electrical Measurements of Single DNA Molecules Translocating Through a Solid State Nanopore JA Bustamante, N Yelle, TC Vincent Biophysical Journal 106 (2), 695a, 2014 | 3 | 2014 |
| Uncovering novel targets of recurrent glioblastoma using transcriptomic profiling in a patient-derived xenograft model N Yelle, C Chokshi, P Vora, KR Brown, MA Qazi, M Singh, JJ Adams, ... Cancer Research 78 (13_Supplement), 1911-1911, 2018 | 1 | 2018 |
| A glioblastoma translational pipeline: discovery of novel tumor antigens that drive GBM recurrence P Vora, C Venugopal, C Chokshi, M Qazi, N Tatari, K Brown, N Yelle, ... Cancer Research 79 (13_Supplement), 570-570, 2019 | | 2019 |
| Identification and validation of DKK1 as a novel candidate therapeutic target for glioblastoma N Yelle | | 2018 |
| TMOD-23. DYNAMIC PATTERNS OF GLIOBLASTOMA CLONAL EVOLUTION IN RESPONSE TO CHEMORADIOTHERAPY M Qazi, C Venugopal, P Vora, A Nixon, K Desmond, M Singh, S Neil, ... Neuro-Oncology 20 (Suppl 6), vi273, 2018 | | 2018 |
| IMMU-03. THERAPEUTIC TARGETING OF TUMORIGENIC EphA2+/EphA3+ BRAIN TUMOR INITIATING CELLS WITH BISPECIFIC ANTIBODY IN HUMAN GLIOBLASTOMA M Qazi, P Vora, C Venugopal, M Gorelik, M Singh, A Hu, M Subapanditha, ... Neuro-Oncology 19 (suppl_6), vi113-vi113, 2017 | | 2017 |
| TMOD-02. IDENTIFICATION OF NOVEL MARKERS OF TREATMENT-REFRACTORY RECURRENT GLIOBLASTOMA N Yelle, C Chokshi, P Vora, C Venugopal, S Singh Neuro-Oncology 19 (suppl_6), vi254-vi254, 2017 | | 2017 |
| THERAPEUTIC TARGETING OF TUMORIGENIC EphA2+/EphA3+ BRAIN TUMOR INITIATING CELLS WITH BISPECIFIC ANTIBODY IN HUMAN GLIOBLASTOMA M Qazi, P Vora, C Venugopal, M Gorelik, M Singh, A Hu, M Subapanditha, ... NEURO-ONCOLOGY 19, 113-113, 2017 | | 2017 |
| TMOD-06. CLONAL DYNAMICS OF HUMAN GLIOBLASTOMA IN RESPONSE TO CHEMORADIOTHERAPY M Qazi, A Nixon, D Bakhshinyan, C Venugopal, P Vora, K Brown, ... Neuro-Oncology 19 (Suppl 6), vi255, 2017 | | 2017 |
| Identification and validation of novel therapeutic targets driving clonal heterogeneity in treatment-refractory GBM C Chokshi, N Yelle, P Vora, C Venugopal, M Qazi, M Singh, ... Cancer Research 77 (13_Supplement), 3844-3844, 2017 | | 2017 |
Tommy AlainChildren's Hospital of Eastern Ontario Research Institute and University of Ottawa在 arc.cheo.ca 的电子邮件经过验证
